Asarina Pharma AB (publ) (STO:ASAP)

Market Cap	919.24K
Revenue (ttm)	n/a
Net Income (ttm)	-12.83M
Shares Out	22.64M
EPS (ttm)	-0.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,303,884
Average Volume	560,703
Open	0.0330
Previous Close	0.0406
Day's Range	0.0280 - 0.0430
52-Week Range	0.0280 - 1.3150
Beta	0.17
RSI	23.16
Earnings Date	Nov 22, 2024

About Asarina Pharma AB

Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 7
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ASAP